DOCSLIB.ORG

SOUTHERN REGIONAL MEETING ABSTRACTS Cardiovascular Club I

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Abstracts SOUTHERN REGIONAL MEETING 2 ATTENUATION OF RENAL FIBROSIS AND ABSTRACTS INFLAMMATION IN NATRIURETIC PEPTIDE RECEPTOR A GENE-TARGETED MICE BY EPIGENETIC Cardiovascular Club I MECHANISMS OF SODIUM BUTYRATE- AND 11:00 AM RETINOIC ACID Thursday, February 18, 2016 P Kumar, R Periyasamy, K Pandey. Tulane University Health Sciences Center, New Orleans, LA 1 ROLE OF CYCLIN DEPENDENT KINASE INHIBITOR 10.1136/jim-2015-000035.2 P27 IN CARDIOMYOCYTE REGENERATION Purpose of Study Mice lacking functional guanylyl SK Sen, H Sadek. UT Southwestern Medical Center, Dallas, TX cyclase/natriuretic peptide receptor-A (GC-A/NPRA) gene 10.1136/jim-2015-000035.1 (Npr1) exhibit hypertension, kidney disease, and heart failure. The objective of the present study was to determine Purpose of Study Neonatal mammalian hearts have the the combined effect of sodium butyrate (NaBu), a histone ability to undergo cardiomyocyte regeneration for a short deacetylase (HDAC) inhibitor and all-trans retinoic acid period of time after birth through proliferation of pre- (ATRA) on attenuation of renal fibrosis and inflammation existing cardiomyocytes. This regenerative window is lost in Npr1 gene-disrupted mutant mice. by the first week of life coinciding with cell cycle arrest. Methods Used Adult (18–20 week old) male Npr1 gene- − The exact mechanism of how postnatal cardiomyocytes disrupted heterozygous (1-copy; Npr1+/ )wild-type regulate proliferation remains unclear. We hypothesize a (2-copy; Npr1+/+), and gene-duplicated (3-copy; Npr1++/+) Kip1 specific cyclin-dependent kinase inhibitor p27 (p27) mice were treated by injecting ATRA-NaBu hybrid drug plays a prominent role in cardiomyocyte proliferation both (1.0 mg/kg/day) intraperitoneally for 2-weeks. in the neonatal period and in adults following myocardial Summary of Results A marked attenuation in − injury. tubulo-interstitial fibrosis was observed in Npr1+/ mice after Methods Used Cardiomyocyte specific α-myosin heavy treatment with ATRA-NaBu (50%, p<0.001). Western blot chain deletion of p27 using Cre recombinase (cKO) mice analyses exhibited the reduction in renal expression of colla- were harvested and compared with wild type (WT) mice in gen type I alpha 2 and transforming growth factor-beta in − the postnatal period. Immunostaining using mitotic markers ATRA-NaBu-treated Npr1+/ mice compared with vehicle- phospho-histone 3 (pH3) and Aurora B kinase (AurB) were treated mice. A significant decrease in systolic blood pressure − used to quantify proliferation along with wheat germ agglu- was observed in ATRA-NaBu-treated Npr1+/ mice. The tinin (WGA) to determine cell size differences. ATRA-NaBu treatment enhanced plasma cGMP levels in − Cardiomyocyte and nucleation counts were done by collage- Npr1+/ , Npr1+/+,andNpr1++/+ mice. Western blot ana- nase digestion. Cardiac function was assessed using M-mode lyses confirmed the reduction in renal expression of tumor echocardiography. Conditional deletion of p27 in the adult necrosis factor-alpha and interleukin-6 in f/f − heart was also investigated using a p27 αMHC ATRA-NaBu-treated Npr1+/ mice compared with control MerCreMer mouse model (iKO) that allowed specific dele- mice. Interestingly, ATRA-NaBu significantly enhanced the tion of p27 following tamoxifen administration. These p27 levels of immunosuppressive cytokine IL-10 in the kidneys of − iKO mice were induced to explore the re-activation of cardi- Npr1+/ , Npr1+/+,andNpr1++/+ mice. Moreover, the − omyocyte mitosis as well as return of function following increased HDAC activity in Npr1+/ mice was markedly ischemic injury. reduced by ATRA-NaBu treatment compared with untreated − Summary of Results p27 cKO extended of the proliferative Npr1+/ control mice. window up to an additional week (6-fold) with no harmful Conclusions The present results provide direct evidence that effect in cardiac function. Proliferation was no longer seen by ATRA-NaBu acts as a potent antifibrotic agent and repairs the − 1 month of age. In the adult mice, p27 iKO showed renal pathology in Npr1+/ mice, which will have important re-activation of mitotic cardiomyocytes throughout the heart implications in prevention of hypertension-related renal (5-fold). In addition, we showed a decrease in cell size pathophysiological conditions. (p=0.023)withnosignificant change in heart weight/body weight ratio. Following myocardial infarction (MI), p27 iKO mice similarly showed robust proliferation throughout the 3 DIFFERENCES IN VENTRICULAR ARRHYTHMIA myocardium as well as a brisk return of cardiac function com- BURDEN BETWEEN HIGH VERSUS LOW POTENCY paredtoWTatsixweekspostMI. STATINS IN PATIENTS WITH NON-ISCHEMIC Conclusions p27 has an important role in cardiomyocyte CARDIOMYOPATHY proliferation both in extending the neonatal proliferative F Al-Saffar,1 C Bennin,2 R Kim1. 1University of Florida – Jacksonville, window and increasing the number of mitotic cardiomyocyte 2 Jacksonville, FL; Valley Cardiology, Fayettville, NC in the adult heart and may have a therapeutic role in regulat- ing cardiomyocyte cell cycle regeneration. 10.1136/jim-2015-000035.3 488 J Investig Med 2016;64:488–726 Abstracts Summary of Results The majority (63%) of the P. had metabolic syndrome (MetS). Analysis by Fisher exact test failed to show significative important correlation with risk factors like diabetes mellitus Type 2, hypertension or hyperlipidemia. 58.7% of patients had angiographic evi- dence of obstructive coronary disease (CAD). Thirty percent of patients had positive C-reactive protein. No prior myocardial infarction or strokes were found. All of them received either pharmacological or revascularization Abstract 3 Figure 1 therapy with angioplasty or bypass surgery. Conclusions In Hispanics, there is a lower incidence of Purpose of Study Ventricular arrhythmia (VA) occurs in CAD compared to Caucasians and African-Americans. We fl patients with ischemic and non-ischemic cardiomyopathy believe that persistent systemic in ammation in psoriasis in fl (NICM). Recent studies have shown that statin therapy conjunction with the up-regulation of in ammatory media- reduces the frequency of VA episodes and the number of tors associated to MetS increases the risk of developing CAD. appropriate implantable Cardioverter-Defibrillator (ICD) This shows that coronary artery disease in young P.withpsor- fl therapies in patients with NICM. We hypothesized that iasis is related to in ammation and not to others risk factors. high potency statins may be more efficacious than low This should be further investigated. potency statins in reducing the number of VA episodes. Methods Used A retrospective study of 102 patients with NICM and ICD (primary prevention) receiving statin 5 ASSOCIATIONS BETWEEN HUNTER TYPE A/B therapy between the years 2000 and 2010 at our institu- PERSONALITY TRAITS AND CARDIOVASCULAR RISK tion. Data was collected through devices for 2 years follow- FACTORS FROM CHILDHOOD TO YOUNG ing the initiation of therapy. If the study subject was ADULTHOOD already on statin, the data was collected for 2 years follow- L Bazzano, B Pollock, W Chen, E Harville. Tulane University School of Public ing ICD implantation. All registered VA episodes were indi- Health and Tropical Medicine, New Orleans, LA vidually reviewed to exclude supraventricular rhythm. Summary of Results The mean age of study subjects was 10.1136/jim-2015-000035.5 59.8 years. Eighty-nine percent were on optimal medical therapy. There was no statistical difference in the mean Purpose of Study Several studies have linked adult Type A number of VA episodes between patients taking high vs. personality with cardiovascular (CV) disease, but evidence low potency statins (p=0.333). There was no difference in is limited regarding associations between childhood person- the mean number of VA episodes between patients taking ality type and CV risk factors. Here, we use the hydrophilic versus lipophilic statins (p=0.154). Diuretics Hunter-Wolf A/B personality trait score to examine child- use was associated with significantly higher VT/VF events hood personality and its cross-sectional and longitudinal (84.4% vs. 68.3%, p= 0.024). associations with traditional CV risk factors. – Conclusions In patients with NICM with a primary pre- Methods Used From 1984 1986, 3,396 children were vention ICD and receiving statin therapy, there was a weak surveyed and multivariable linear regression was used to trend (not statistically significant) toward a fewer number test adjusted associations between personality and CV risk of VA episodes in patients receiving high (compared to factors. To test longitudinal associations, subjects were fol- low) potency statins. lowed through 2007 and general estimating equation models examined changes in risk factors and their associa- tions with childhood personality traits. 4 THE ATHEROSCLEROTIC PROCESS IN PSORIASIS IS DIRECTLY RELATED TO INFLAMMATION J Nieves,1 C Sulia,1 PI Altieri,1,2 L Figueroa,1 H Banchs,1,2 W González1. 1University of Puerto Rico, School of Medicine, San Juan, PR; 2Cardiovascular Center of Puerto Rico and the Caribbean, San Juan, PR 10.1136/jim-2015-000035.4 Purpose of Study We intended to study the morbidity and mortality in patients (P.) with psoriasis and find out if inflammation is the most important factor. Methods Used Retrospective study of 46 patients with moderate to severe psoriasis admitted to the Cardiovascular Center of Puerto Rico and the Caribbean from 2007 to 2013 due to chest pain and suspected myo- cardial infarct. Coronary angiographic reports were reviewed and analyzed statistically by Fisher exact test with risk factors like diabetes mellitus, hypertension or hyperlip- idemia. Population median age was 56 years and 72% were males. Abstract 5 Figure 1 J Investig Med 2016;64:488–726 489 Abstracts Summary of Results Mean(±SD) Hunter A/B score was 24 h: high Na diet) and PA status. LVH reduction was 96.9±11.6, with 1,730 (50.9%) Type A subjects. After indexed by left ventricular mass (LVM) and interventricular adjustment, alcohol use, gender, race, and BMI were asso- septum thickness (IVS) regression. ciated with childhood personality (p<.0001, p<.0001, Summary of Results LVM and IVS regression after treat- p=.03, and p=.06 respectively).
Recommended publications
  • OM-85) on Frequency of Upper Respiratory Tract Infections and Size of Adenoid Tissue in Preschool Children with Adenoid Hypertrophy

    OM-85) on Frequency of Upper Respiratory Tract Infections and Size of Adenoid Tissue in Preschool Children with Adenoid Hypertrophy

    STUDY PROTOCOL Effect of Vaxoral® (OM-85) on frequency of upper respiratory tract infections and size of adenoid tissue in preschool children with adenoid hypertrophy Study Product(s) Vaxoral® (OM-85) Indication Recurrent RTIs, adenoid hypertrophy Sponsor Dr Sami Ulus Maternity and Children Research and Training Hospital, Department of Pediatric Allergy and Immunology, Ankara, TURKEY Anticipated Turkey Countries Introduction OM-85 significantly reduces RTIs in children. This effect was proved by many clinical studies and meta-analyses1. A Cochrane meta-analysis first published in 2006 and updated recently (Del- Rio-Navarro 2012) showed that immunostimulants (IS) could reduce acute RTIs (ARTIs) by almost 39% when compared to placebo. Among the different IS, OM-85 showed the most robust evidence with 4 trials of “A quality” according to the Cochrane grading criteria. Pooling six OM-85 studies, the Cochrane review reported a mean number of ARTIs reduction by -1.20 [95% CI: - 1.75, -0.66] and a percentage difference in ARTIs by -35.9% [95% CI: -49.46, -22.35] compared to placebo1. Adenoid hypertrophy (AH) is one of the most important respiratory disease in preschool children2. In normal conditions adenoid tissue enlarges up to 5 years and become smaller afterwards. But in some children who have recurrent URTIs, it keeps growing and this can be associated with complications2. AH may cause recurrent respiratory infections and each infection contributes to enlargement of adenoid tissue thus promoting a vicious cycle. Additionally enlarged adenoids are known to be reservoir for microbes and cause of recurrent or long lasting RTIs3. AH is associated with chronic cough, recurrent and chronic sinusitis, recurrent tonsillitis, recurrent otitis media with effusion, recurrent other respiratory problems such as, nasal obstruction and sleep disturbances, sleep apneas2-3.
  • MRI Changes of Brain in Newborns with Hypoxic Ischemic Encephalopathy Clinical Stage Ii Or Stage Iii- a Descriptive Study

    MRI Changes of Brain in Newborns with Hypoxic Ischemic Encephalopathy Clinical Stage Ii Or Stage Iii- a Descriptive Study

    Original Research Article DOI: 10.18231/2455-6793.2017.0009 MRI changes of brain in newborns with hypoxic ischemic encephalopathy clinical stage ii or stage iii- a descriptive study Jose O1,*, Sheena V2 1Assistant Professor, 2Junior Resident, Dept. of Pediatrics, Govt. TD Medical College, Alappuzha *Corresponding Author: Email: [email protected] Abstract Objectives: The aim of the study was to estimate the proportion of MRI changes in newborns with HIE, to compare the findings of term and preterm babies and to identify if there is any clinical stage specific MRI findings Methods: After obtaining clearance from ethical committee, 30 newborns with either stage II or stage III HIE are included in the study. MRI brain was taken between one to two weeks of age once the vitals of the babies are stable & after ensuring euthermia. Results: Out of the 30 babies, 19 were male babies and 11 female babies. 16 of them were term and 14 of them preterm babies.27 of the total 30 patients had MRI changes of HIE, which accounts for 90%. 17of the 30 mothers were primi mothers which accounts for 56.7%. Most important antenatal factors associated with HIE are gestational hypertension and UTI. Gestational diabetes mellitus and placental/cord factors are also found to be important contributing factors. 33.4% had a history of UTI, 30% gestational hypertension, 23.4% gestational diabetes mellitus in the antenatal period. Conclusion: Basal ganglia and/or thalamus were affected in 50% of term babies. 87.5% of babies with periventricular leucomalacia are preterms. Intracranial hemorrhage was seen in 7.4% of the babies and all of them were preterms.
  • Melbourne Radio

    Melbourne Radio

    EMBARGOED UNTIL 9:30AM (AEST) MELBOURNE RADIO - SURVEY 4 2021 Share Movement (%) by Demographic, Mon-Sun 5.30am-12midnight People 10+ People 10-17 People 18-24 People 25-39 People 40-54 People 55-64 People 65+ Station This Last +/- This Last +/- This Last +/- This Last +/- This Last +/- This Last +/- This Last +/- SEN 1116 2.8 2.9 -0.1 1.6 0.9 0.7 0.5 0.1 0.4 3.1 1.4 1.7 3.2 2.6 0.6 3.3 6.0 -2.7 2.8 3.8 -1.0 3AW 15.5 15.6 -0.1 5.9 2.0 3.9 0.4 1.5 -1.1 3.6 3.2 0.4 13.1 11.2 1.9 17.6 22.4 -4.8 32.5 32.8 -0.3 RSN 927 0.3 0.4 -0.1 * * * * 0.1 * * * * 0.4 0.1 0.3 0.5 0.5 0.0 0.4 1.1 -0.7 Magic 1278 1.3 1.0 0.3 * 0.1 * 0.7 0.2 0.5 1.6 0.6 1.0 1.4 0.7 0.7 1.4 1.0 0.4 1.5 1.9 -0.4 3MP 1377 1.0 0.9 0.1 0.1 * * * 0.2 * 0.1 0.1 0.0 0.8 1.3 -0.5 2.5 0.7 1.8 1.7 1.8 -0.1 101.9 FOX FM 7.0 7.8 -0.8 14.8 16.4 -1.6 11.3 10.3 1.0 13.4 14.3 -0.9 7.1 10.4 -3.3 3.8 3.6 0.2 0.6 0.1 0.5 GOLD104.3 10.4 11.1 -0.7 5.8 8.6 -2.8 11.3 13.1 -1.8 10.7 9.2 1.5 15.0 14.9 0.1 15.7 15.1 0.6 3.8 6.5 -2.7 KIIS 101.1 FM 5.5 6.4 -0.9 15.4 18.1 -2.7 10.7 14.4 -3.7 9.8 10.4 -0.6 4.9 5.9 -1.0 2.5 3.5 -1.0 0.5 0.2 0.3 105.1 TRIPLE M 4.7 5.2 -0.5 2.8 2.0 0.8 8.0 6.6 1.4 7.0 5.8 1.2 6.2 8.0 -1.8 4.7 8.2 -3.5 0.9 0.8 0.1 NOVA 100 6.7 7.8 -1.1 21.2 22.4 -1.2 11.4 14.5 -3.1 8.4 12.6 -4.2 7.6 8.9 -1.3 4.8 3.1 1.7 0.4 0.3 0.1 smoothfm 91.5 7.8 7.6 0.2 6.9 8.7 -1.8 5.9 3.3 2.6 6.5 5.5 1.0 7.8 7.7 0.1 9.4 8.0 1.4 8.9 10.1 -1.2 ABC MEL 11.1 8.8 2.3 2.3 1.0 1.3 5.5 2.8 2.7 4.3 4.5 -0.2 6.3 4.3 2.0 13.8 6.4 7.4 23.2 21.6 1.6 3RN 2.7 2.1 0.6 0.6 0.4 0.2 * * * 0.7 0.2 0.5 2.2 1.2 1.0 2.6 2.7
  • Prognostication in Neonatal Hypoxic Ischemic Encephalopathy: a Qualitative Research Study

    Prognostication in Neonatal Hypoxic Ischemic Encephalopathy: a Qualitative Research Study

    Prognostication in Neonatal Hypoxic Ischemic Encephalopathy: A Qualitative Research Study Lisa Anne Rasmussen Department of Medicine, Division of Experimental Medicine and Biomedical Ethics Unit McGill University Montreal, Quebec, Canada November 2017 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Master of Science in Experimental Medicine, Specialization in Biomedical Ethics ©Lisa Anne Rasmussen, 2017 Abstract Background Hypoxic ischemic encephalopathy is the most frequent cause of neonatal encephalopathy, and results in significant morbidity and mortality. From an ethical and clinical standpoint, neurological prognosis is fundamental in the care of neonates with hypoxic ischemic encephalopathy. However, accurately predicting neurodevelopmental outcomes for neonatal hypoxic ischemic encephalopathy is particular difficult, and fraught with challenges. At present, focused research in this area is limited. Objectives This thesis aims to present a review of the current literature on prognosis and the practice of prognostication in neonatal hypoxic ischemic encephalopathy, focusing on the integral challenges posed by this vulnerable group of neonates. Furthermore, this thesis incorporates an original qualitative study that explores physician perspectives about prognostication in neonatal hypoxic ischemic encephalopathy. The main objective of this thesis is to advance the current understanding of the practice of prognostication in neonatal hypoxic ischemic encephalopathy, in hopes of opening
  • Clinical Study Microbiological Profile of Adenoid Hypertrophy Correlates to Clinical Diagnosis in Children

    Clinical Study Microbiological Profile of Adenoid Hypertrophy Correlates to Clinical Diagnosis in Children

    Hindawi Publishing Corporation BioMed Research International Volume 2013, Article ID 629607, 10 pages http://dx.doi.org/10.1155/2013/629607 Clinical Study Microbiological Profile of Adenoid Hypertrophy Correlates to Clinical Diagnosis in Children Anita Szalmás,1 Zoltán Papp,2 Péter Csomor,2 József Kónya,1 István Sziklai,2 Zoltán Szekanecz,3 and Tamás Karosi2 1 Department of Medical Microbiology, Medical and Health Science Center, University of Debrecen, Nagyerdei Krt. 98, Debrecen 4032, Hungary 2 Department of Otolaryngology and Head and Neck Surgery, Medical and Health Science Center, University of Debrecen, Nagyerdei Krt. 98, Debrecen 4032, Hungary 3 Department of Rheumatology, Medical and Health Science Center, University of Debrecen, Nagyerdei Krt. 98, Debrecen 4032, Hungary Correspondence should be addressed to Tamas´ Karosi; [email protected] Received 24 April 2013; Accepted 23 August 2013 Academic Editor: Ralph Mosges¨ Copyright © 2013 Anita Szalmas´ et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective. Adenoid hypertrophy is a common condition in childhood, which may be associated with recurring acute otitis media (RAOM), otitis media with effusion (OME), and obstructive sleeppnea a syndrome (OSAS). These different clinical characteristics have some clinical overlap; however, they might be explained by distinct immunologic and infectious profiles and result in various histopathologic findings of adenoid specimens. Methods. A total of 59 children with adenoid hypertrophy undergoing adenoidectomy were studied. Three series of identical adenoid specimens were processed to hematoxylin-eosin (H.E.) and Gram staining and to respiratory virus specific real-time PCR, respectively.
  • 235 © Springer Nature Switzerland AG 2019 G. I. Martin, W. Rosenfeld

    235 © Springer Nature Switzerland AG 2019 G. I. Martin, W. Rosenfeld

    Index A hemolytic disease, 90 Abdominal distension, 161, 166 hereditary elliptocytosis, 97 Aberrant ventricular conduction, 153, 154, 156 hereditary spherocytosis, 97 Absent uvula, 31 initial laboratory assessment, 94 Adenoviral conjunctivitis, 221 packed red blood cell transfusion, 94 Adenovirus, 77 peripheral smear, 96 Alopecia, 18 red cell indices, reference range, 90 Ambiguous genitalia reticulocyte count, 96 androgen insensitivity syndrome, 211 Rh incompatibility, 90 CAH (see Congenital adrenal hyperplasia (CAH)) rhinovirus, 97 causes of, 206, 211 signs and symptoms, 89, 94 chromosomal analysis, 205, 209 sources of blood loss, 94 DSD, 205 subgaleal hemorrhages, 92 evaluation of, 210 transfusion guidelines, 95 genetic factors for, 204 vascular access, 94 21-hydroxylase deficiency, 207 vital signs per nursery protocol, 92 incidence of, 203 Ankyloglossia, 31 pelvic sonogram, 209 Antacids, 166 sex assignment, 211 Antiarrhythmic medications, 150 sex determination and differentiation, 204 Anti-Ro and anti-La maternal antibodies, 152 46 XY karyotype and, 206 Apgar score, 183, 184 Amblyopia, 218 Aplasia cutis congenita (ACC), 44, 45 American Congress of Obstetricians and Gynecologists Arrhythmia (ACOG), 2, 55, 57 antiarrhythmic medications, 150 Amplitude electroencephalograph (aEEG), 6, 9 benign arrhythmias, 149 Androgen insensitivity syndrome (AIS), 209, 211 bradyarrhythmia Anemia atrioventricular block, 152, 153 ABO incompatibility, 90 EKG rhythm, 151 acute blood loss, 93 initial therapy, 151 blood transfusion therapy, 95, 96 management,
  • VFL Record 2014 Rnd 24.Indd

    VFL Record 2014 Rnd 24.Indd

    $5.00 VFL & TAC CUP GRAND FINALS SEPTEMBER 21, 2014 FFootscrayootscray BBulldogsulldogs 220.10.1300.10.130 d PPortort MMelbourneelbourne 114.14.984.14.98 BBoxox HHillill HHawksawks 115.10.1005.10.100 d WWilliamstownilliamstown 114.9.934.9.93 AFL VICTORIA CORPORATE PARTNERS NAMING RIGHTS PREMIER PARTNERS OFFICIAL PARTNERS APPROVED LICENSEES Contents EVERY WEEK FEATURES 22 Club Notes 6 - 9 Grant Williams Q & A 50 - 51 Statistics 11 Development League Grand Final 54 - 55 Last Word 27 - 29 VFL Team of the Year 56 Tipsters 45 - 47 TAC Cup Team of the Year GAME TIME 24 - 25 VFL GF Preview 30 - 31 Footscray Profi les 32 - 33 VFL Team Lists 34 - 35 Box Hill Profi les 36 - 37 TAC Cup GF Preview 38 - 39 Calder Profi les 40 - 41 TAC Cup Team Lists 42 - 43 Oakleigh Profi les www.vfl .com.au 1 MEDIA COVERAGE - VFL & TAC CUP ABC TV Sunday September 21: Footscray v Box Hill Hawks, 2pm Watch a replay on iView an hour after the completion of the match VFL Radio Sunday September 21: Footscray v Box Hill Hawks. From 1:30pm Live on Digital Radio via Aussie, Red Time Sport and SEN I-Phone Apps, online via vfl .com.au or sen.com.au and on Vision Australia Radio on 1179AM or SEN 1116am 3WBC Sunday September 21: Footscray v Box Hill Hawks, 1pm Listen to 94.1FM, online at www.3wbc.org.au or the Tune In Radio app SEN Thursday September 25 The Peter Jackson VFL Show 8:30pm – 9pm Peter Jackson VFL Podcast Visit the VFL website each Tuesday for the Peter Jackson VFL Podcast.
  • Mediastinum and Subcutaneous Emphysema: a Rare Complication of a Common Procedure

    Mediastinum and Subcutaneous Emphysema: a Rare Complication of a Common Procedure

    Case Report Brunei Int Med J. 2017; 13 (1): 29-32 Post adenotonsillectomy pneumo- mediastinum and subcutaneous emphysema: A rare complication of a common procedure. Farah Wahida ABD MANAB1,2, Nor Shahida ABDUL MUTALLIB1, Hisham ABDUL RAH- MAN1, Hamidah MAMAT1 1Department of otorhinolaryngology-Head and Neck surgery, Hospital Sultan Abdul Halim, Kedah, Malaysia, 2Department of Otorhinolaryngology, Head and Neck Surgery, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia ABSTRACT Cervicofacial and pneumomediastinum subcutaneous emphysema is a very rare complication of adenotonsillectomy procedure. Even though it is a self limiting complication and can be treated conservatively, it can alarming for the patient or patient’s family as well as leading to more seri- ous and fatal consequences occurring from tension pneumomediastinum. We report a case of incidental finding of pneumomediastinum in postadenotonsillectomy patient. He was managed conservatively and made an uneventful recovery. Keywords: tonsillectomy, subcutaneous emphysema, complication INTRODUCTION Case Report Adenotonsillectomy is a common surgical pro- A 12 year old boy was admitted to our Ear, cedure among paediatric age group. It is rela- Nose and Throat (ENT) ward for elective sur- tively a safe procedure with minimal compli- gery of adenotonsillectomy. The indication for cations. Common complications are intraoper- surgery was recurrent attacks of acute tonsil- ative or postoperative haemorrhage, infec- litis. He had underlying Allergic Rhinitis and tion, damaged to soft tissue and surrounding Bronchial Asthma. structure such as teeth, odynophagia and oropharyngeal edema.1 Cervicofacial and Patient was given general anaesthesia with pneumomediastinum subcutaneous emphyse- fentanyl, propofol and cisatracium during in- ma is a very rare complication.
  • Perinatal Asphyxia in the Term Newborn

    Perinatal Asphyxia in the Term Newborn

    www.jpnim.com Open Access eISSN: 2281-0692 Journal of Pediatric and Neonatal Individualized Medicine 2014;3(2):e030269 doi: 10.7363/030269 Received: 2014 Oct 01; accepted: 2014 Oct 14; published online: 2014 Oct 21 Review Perinatal asphyxia in the term newborn Roberto Antonucci1, Annalisa Porcella1, Maria Dolores Pilloni2 1Division of Neonatology and Pediatrics, “Nostra Signora di Bonaria” Hospital, San Gavino Monreale, Italy 2Family Planning Clinic, San Gavino Monreale, ASL 6 Sanluri (VS), Italy Proceedings Proceedings of the International Course on Perinatal Pathology (part of the 10th International Workshop on Neonatology · October 22nd-25th, 2014) Cagliari (Italy) · October 25th, 2014 The role of the clinical pathological dialogue in problem solving Guest Editors: Gavino Faa, Vassilios Fanos, Peter Van Eyken Abstract Despite the important advances in perinatal care in the past decades, asphyxia remains a severe condition leading to significant mortality and morbidity. Perinatal asphyxia has an incidence of 1 to 6 per 1,000 live full-term births, and represents the third most common cause of neonatal death (23%) after preterm birth (28%) and severe infections (26%). Many preconceptional, antepartum and intrapartum risk factors have been shown to be associated with perinatal asphyxia. The standard for defining an intrapartum hypoxic-ischemic event as sufficient to produce moderate to severe neonatal encephalopathy which subsequently leads to cerebral palsy has been established in 3 Consensus statements. The cornerstone of all three statements is the presence of severe metabolic acidosis (pH < 7 and base deficit ≥ 12 mmol/L) at birth in a newborn exhibiting early signs of moderate or severe encephalopathy. Perinatal asphyxia may affect virtually any organ, but hypoxic-ischemic encephalopathy (HIE) is the most studied clinical condition and that is burdened with the most severe sequelae.
  • Role of Thompson Score in Predicting Neurodevelopmental Outcome

    Role of Thompson Score in Predicting Neurodevelopmental Outcome

    ROLE OF THOMPSON SCORE IN PREDICTING NEURODEVELOPMENTAL OUTCOME Dissertation submitted to THE TAMILNADU DR.M.G.R.MEDICAL UNIVERSITY In partial fulfilment of the regulations for the award of degree of M.D DEGREE (PEDIATRICS) BRANCH VII INSTITUTE OF SOCIAL PEDIATRICS STANLEY MEDICAL COLLEGE CHENNAI – 600 001 APRIL 2016 DECLARATION I, Dr.B.RUPA , solemnly declare that the dissertation titled “ROLE OF THOMPSON SCORE IN PREDICTING NEURODEVELOPMENTAL OUTCOME”was doneby me at Government Stanley MedicalCollege during 2013- 2016 under the guidance and supervision of my chief Prof. SHANTHI M.D, D.C.H. The dissertation is submitted to The Tamil Nadu Dr.M.G.R Medical University towards the partial fulfilment of the rules and regulations for the M.D. Degree Examination - BRANCH VII - in Pediatrics . Signature of the candidate Dr.B.RUPA Place : Chennai Date: CERTIFICATE BY THE GUIDE This is to certify that the dissertation titled “ROLE OF THOMPSON SCORE IN PREDICTING NEURO DEVELOPMENTAL OUTCOME” is a bonafide research work done under my guidance by Dr.B.RUPA, Postgraduate student, Department of Pediatrics, Government Stanley medical college, The Tamil Nadu Dr.M.G.R Medical University, Chennai, in partial fulfilment of the requirement of the award for the degree of M.D PEDIATRICS - BRANCH VII. Place : Chennai Signature of the guide Date : Dr.Aravind MD, DCH Professor of NICU RSRM hospital Institute of Social Pediatrics Stanley medical college, Chennai – 600001 CERTIFICATE BY THE INSTITUTION This is to certify that the dissertation titled “ROLE OF THOMPSON SCORE IN PREDICTING NEURO DEVLOPMENTAL OUTCOME”is submitted by Dr.B.RUPA to The Tamilnadu Dr.M.G.R Medical University, Chennai in partial fulfilment of the requirement of the award for the degree of M.D BRANCH VII (PEDIATRICS) and is a bonafide work done by her under our direct supervision and guidance, during the academic year 2014 -2015 Place: Chennai DR.Aravind MD, DCH Date: Professor of NICU RSRM Hospital Institute of Social Pediatrics Stanley Medical College Chennai –600001.
  • The Magazine of the Community Broadcasting Association of Australia

    The Magazine of the Community Broadcasting Association of Australia

    NOVEMBER 2012 || The Magazine of the Community Broadcasting Association of Australia National Listener Survey Results || Radio With Pictures || Networking The News 8 10 contents President's Column ....................................................... 2 CBAA Update ............................................................... 3 National Listener Survey.............................................. 4 12 Project News ................................................................. 6 By Invitation ................................................................. 7 Networking the News ................................................... 8 Small Talk .................................................................. 10 Radio with Pictures .................................................... 12 Radio Days ................................................................. 15 Across the Sector ....................................................... 16 Station to Station ........................................................ 19 20 Making Radio ............................................................. 20 Getting the Message Across ....................................... 22 24 Out of the Box ............................................................ 24 2 The Magazine of the Community Broadcasting Association of Australia • November 2012 E CBAA H T M O Conference, R F S W IE CBX is the magazine of the D V Community Broadcasting Association an Codes, Campaigns, of Australia. W NES CBX is mailed to CBAA members and stakeholders. Subscribe
  • Echocardiographic Characteristics of Nigerian Children with Adenoidal

    Echocardiographic Characteristics of Nigerian Children with Adenoidal

    nal atio Me sl d n ic a in r e T Animasahun et al., Transl Med (Sunnyvale) 2016, 6:4 Translational Medicine DOI: 10.4172/2161-1025.1000189 ISSN: 2161-1025 Research Article Open Access Echocardiographic Characteristics of Nigerian Children with Adenoidal Hypertrophy: A Multicenter Study Barakat Adeola Animasahun*, Motunrayo O Adekunle, Henry Olusegun Gbelee and Olisamedua Fidelis Njokanma Department of Paediatrics Lagos State University Teaching Hospital Ikeja, Lagos, Nigeria *Corresponding author: Adeola Barakat Animasahun, Lagos State University College of Medicine, Lagos, Nigeria, Tel: +2348055341166; Fax: 2348037250264; E-mail: [email protected] Recieved date: October 27, 2016; Accepted date: November 07, 2016; Published date: November 14, 2016 Copyright: © 2016 Animasahun AB, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Background: Adenoidal hypertrophy is a common respiratory disease in childhood with a lethal complication of Cor-Pulmonale. There are few studies on the prevalence of adenoidal hypertrophy in children in Nigeria. The aim of the current study is to document the echocardiographic characteristics of Nigerian Children with adenoidal hypertrophy and compare the findings with those of other children in other parts of the world. Method: The study was prospective, involving subjects from three centers which were; a tertiary hospital, a private hospital and a major cardiology center. Children with clinical and radiological diagnosis of adenoidal hypertrophy had transthoracic echocardiography done by a cardiologist. Results: A total of 1,346 children had echocardiography done within the three years studied period in the centers.